Login or Sign Up
Alivus Life Sciences Ltd. Corporate Actions
15:55 May 30
Alivus Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Alivus Life Sciences Ltd. Corporate Actions
Alivus Life Sciences Ltd.
Industry Pharmaceuticals
15:55 May 30
Quality
43/100
Medium Financial Strength
Valuation
32/100
Mid Valuation
Technical
46/100
Technically Neutral
Strength
9
Weakness
8
Opportunity
1
Threats
0
0.00 %
Dividend Yield
12.76K
Market Cap (Cr)
40.42
RSI
74.99 %
Promoter Holding
0.00 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 17-Oct-2023 | Dividend | 22.50/share@1,125.00% | 17-Oct-2023 | 1,125.00 | Interim |
| 24-Mar-2023 | Dividend | 21.00/share@1,050.00% | 24-Mar-2023 | 1,050.00 | Interim |
| 15-Sep-2022 | Dividend | 10.50/share@525.00% | - | 525.00 | Final |
| 22-Nov-2021 | Dividend | 10.50/share@525.00% | 23-Nov-2021 | 525.00 | Interim |
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
